explore
Previous article:
Supreme Court strikes down use of affirmative action
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
focus
explore
-
Ventyx halts psoriasis drug development after lackluster trial results
2025-09-27 18:29 -
UnitedHealth sued over use of algorithm in Medicare Advantage plans
2025-09-27 17:28 -
Medical school prerequisites are outdated
2025-09-27 17:15 -
For Medicare Advantage, Democrats want stronger protections around AI
2025-09-27 16:56 -
Gilead might be held responsible for not developing a drug
2025-09-27 16:34 -
Medicare threatens to cut off funding for HCA's Mission hospital
2025-09-27 16:19